tooluniverse-chemical-compound-retrieval
Retrieves chemical compound information from PubChem and ChEMBL with disambiguation, cross-referencing, and quality assessment. Creates comprehensive compound profiles with identifiers, properties, bioactivity, and drug information. Use when users need chemical data, drug information, or mention PubChem CID, ChEMBL ID, SMILES, InChI, or compound names.
Best use case
tooluniverse-chemical-compound-retrieval is best used when you need a repeatable AI agent workflow instead of a one-off prompt.
Retrieves chemical compound information from PubChem and ChEMBL with disambiguation, cross-referencing, and quality assessment. Creates comprehensive compound profiles with identifiers, properties, bioactivity, and drug information. Use when users need chemical data, drug information, or mention PubChem CID, ChEMBL ID, SMILES, InChI, or compound names.
Teams using tooluniverse-chemical-compound-retrieval should expect a more consistent output, faster repeated execution, less prompt rewriting.
When to use this skill
- You want a reusable workflow that can be run more than once with consistent structure.
When not to use this skill
- You only need a quick one-off answer and do not need a reusable workflow.
- You cannot install or maintain the underlying files, dependencies, or repository context.
Installation
Claude Code / Cursor / Codex
Manual Installation
- Download SKILL.md from GitHub
- Place it in
.claude/skills/tooluniverse-chemical-compound-retrieval/SKILL.mdinside your project - Restart your AI agent — it will auto-discover the skill
How tooluniverse-chemical-compound-retrieval Compares
| Feature / Agent | tooluniverse-chemical-compound-retrieval | Standard Approach |
|---|---|---|
| Platform Support | Not specified | Limited / Varies |
| Context Awareness | High | Baseline |
| Installation Complexity | Unknown | N/A |
Frequently Asked Questions
What does this skill do?
Retrieves chemical compound information from PubChem and ChEMBL with disambiguation, cross-referencing, and quality assessment. Creates comprehensive compound profiles with identifiers, properties, bioactivity, and drug information. Use when users need chemical data, drug information, or mention PubChem CID, ChEMBL ID, SMILES, InChI, or compound names.
Where can I find the source code?
You can find the source code on GitHub using the link provided at the top of the page.
SKILL.md Source
# Chemical Compound Information Retrieval
Retrieve comprehensive chemical compound data with proper disambiguation and cross-database validation.
**IMPORTANT**: Always use English compound names and search terms in tool calls, even if the user writes in another language (e.g., translate "阿司匹林" to "aspirin"). Only try original-language terms as a fallback if English returns no results. Respond in the user's language.
## Workflow Overview
```
Phase 0: Clarify (if needed)
↓
Phase 1: Disambiguate Compound Identity
↓
Phase 2: Retrieve Data (Internal)
↓
Phase 3: Report Compound Profile
```
---
## Phase 0: Clarification (When Needed)
Ask the user ONLY if:
- Compound name is highly ambiguous (e.g., "vitamin E" → α, β, γ, δ-tocopherol?)
- Multiple distinct compounds share the name (e.g., "aspirin" is clear; "sterol" is not)
Skip clarification for:
- Unambiguous drug names (aspirin, ibuprofen, metformin)
- Specific identifiers provided (CID, ChEMBL ID, SMILES)
- Clear structural queries (SMILES, InChI)
---
## Phase 1: Compound Disambiguation
### 1.1 Resolve Primary Identifier
```python
from tooluniverse import ToolUniverse
tu = ToolUniverse()
tu.load_tools()
# Strategy depends on input type
if user_provided_cid:
cid = user_provided_cid
elif user_provided_smiles:
result = tu.tools.PubChem_get_CID_by_SMILES(smiles=smiles)
cid = result["data"]["cid"]
elif user_provided_name:
result = tu.tools.PubChem_get_CID_by_compound_name(compound_name=name)
cid = result["data"]["cid"]
```
### 1.2 Cross-Reference Identifiers
Always establish compound identity across both databases:
```python
# PubChem → ChEMBL cross-reference
chembl_result = tu.tools.ChEMBL_search_compounds(query=compound_name, limit=5)
if chembl_result["data"]:
chembl_id = chembl_result["data"][0]["molecule_chembl_id"]
```
### 1.3 Handle Naming Collisions
For generic names (e.g., "vitamin", "steroid", "acid"):
- Search returns multiple CIDs → present top matches with structures
- Verify SMILES/InChI matches user intent
- Note stereoisomers or salt forms if relevant
**Identity Resolution Checklist:**
- [ ] PubChem CID established
- [ ] ChEMBL ID cross-referenced (if exists)
- [ ] Canonical SMILES captured
- [ ] Stereochemistry noted (if relevant)
- [ ] Salt forms identified (if applicable)
---
## Phase 2: Data Retrieval (Internal)
Retrieve all data silently. Do NOT narrate the search process.
### 2.1 Core Properties (PubChem)
```python
# Basic properties
props = tu.tools.PubChem_get_compound_properties_by_CID(cid=cid)
# Bioactivity summary
bio = tu.tools.PubChem_get_bioactivity_summary_by_CID(cid=cid)
# Drug label (if approved drug)
drug = tu.tools.PubChem_get_drug_label_info_by_CID(cid=cid)
# Structure image
image = tu.tools.PubChem_get_compound_2D_image_by_CID(cid=cid)
```
### 2.2 Bioactivity Data (ChEMBL)
```python
if chembl_id:
# Detailed bioactivity
activity = tu.tools.ChEMBL_get_bioactivity_by_chemblid(chembl_id=chembl_id)
# Protein targets
targets = tu.tools.ChEMBL_get_target_by_chemblid(chembl_id=chembl_id)
# Assay data
assays = tu.tools.ChEMBL_get_assays_by_chemblid(chembl_id=chembl_id)
```
### 2.3 Optional Extended Data
```python
# Patents (for drugs)
patents = tu.tools.PubChem_get_associated_patents_by_CID(cid=cid)
# Similar compounds (for SAR)
similar = tu.tools.PubChem_search_compounds_by_similarity(cid=cid, threshold=85)
```
### Fallback Chains
| Primary | Fallback | Notes |
|---------|----------|-------|
| PubChem_get_CID_by_compound_name | ChEMBL_search_compounds → get SMILES → PubChem_get_CID_by_SMILES | Name lookup failed |
| ChEMBL_get_bioactivity | PubChem_get_bioactivity_summary | ChEMBL ID unavailable |
| PubChem_get_drug_label_info | Note "Drug label unavailable" | Not an approved drug |
---
## Phase 3: Report Compound Profile
### Output Structure
Present results as a **Compound Profile Report**. Hide all search process details.
```markdown
# Compound Profile: [Compound Name]
## Identity
| Property | Value |
|----------|-------|
| **PubChem CID** | [cid] |
| **ChEMBL ID** | [chembl_id or "N/A"] |
| **IUPAC Name** | [full name] |
| **Common Names** | [synonyms] |
## Chemical Properties
### Molecular Descriptors
| Property | Value | Drug-Likeness |
|----------|-------|---------------|
| **Formula** | C₉H₈O₄ | - |
| **Molecular Weight** | 180.16 g/mol | ✓ (<500) |
| **LogP** | 1.19 | ✓ (-2 to 5) |
| **H-Bond Donors** | 1 | ✓ (<5) |
| **H-Bond Acceptors** | 4 | ✓ (<10) |
| **Polar Surface Area** | 63.6 Ų | ✓ (<140) |
| **Rotatable Bonds** | 3 | ✓ (<10) |
### Structural Representation
- **SMILES**: `CC(=O)Oc1ccccc1C(=O)O`
- **InChI**: `InChI=1S/C9H8O4/...`
[2D structure image if available]
## Bioactivity Profile
### Summary
- **Active in**: [X] assays out of [Y] tested
- **Primary Targets**: [list top targets]
- **Mechanism**: [if known]
### Key Target Interactions (from ChEMBL)
| Target | Activity Type | Value | Units |
|--------|--------------|-------|-------|
| [Target 1] | IC50 | [value] | nM |
| [Target 2] | Ki | [value] | nM |
## Drug Information (if applicable)
### Clinical Status
| Property | Value |
|----------|-------|
| **Approval Status** | [Approved/Investigational/N/A] |
| **Drug Class** | [therapeutic class] |
| **Indication** | [approved uses] |
| **Route** | [oral/IV/topical/etc.] |
### Safety
- **Black Box Warning**: [Yes/No]
- **Major Interactions**: [if any]
## Related Compounds (if retrieved)
Top 5 structurally similar compounds:
| CID | Name | Similarity | Key Difference |
|-----|------|------------|----------------|
| [cid] | [name] | 95% | [note] |
## Data Sources
- PubChem: [CID link]
- ChEMBL: [ChEMBL ID link]
- Retrieved: [date]
```
---
## Data Quality Tiers
Apply to data completeness assessment:
| Tier | Symbol | Criteria |
|------|--------|----------|
| Complete | ●●● | All core properties + bioactivity + drug info |
| Substantial | ●●○ | Core properties + bioactivity OR drug info |
| Basic | ●○○ | Core properties only |
| Minimal | ○○○ | CID/name only, limited data |
Include in report header:
```markdown
**Data Completeness**: ●●● Complete (properties, bioactivity, drug data)
```
---
## Completeness Checklist
Every compound profile MUST include these sections (even if "unavailable"):
### Identity (Required)
- [ ] PubChem CID
- [ ] ChEMBL ID (or "N/A")
- [ ] IUPAC name
- [ ] Canonical SMILES
### Properties (Required)
- [ ] Molecular formula
- [ ] Molecular weight
- [ ] LogP
- [ ] Lipinski rule assessment
### Bioactivity (Required)
- [ ] Activity summary (or "No bioactivity data")
- [ ] Primary targets (or "Unknown")
### Drug Info (If Approved Drug)
- [ ] Approval status
- [ ] Indication
- [ ] Drug class
### Always Include
- [ ] Data sources with links
- [ ] Retrieval date
- [ ] Quality tier assessment
---
## Common Use Cases
### Drug Property Check
User: "Tell me about metformin"
→ Full compound profile with drug information emphasis
### Structure Verification
User: "Verify this SMILES: CC(=O)Oc1ccccc1C(=O)O"
→ Disambiguation-focused profile, confirm identity
### SAR Analysis
User: "Find compounds similar to ibuprofen"
→ Similarity search + comparative property table
### Target Identification
User: "What proteins does gefitinib target?"
→ ChEMBL bioactivity emphasis with target list
---
## Error Handling
| Error | Response |
|-------|----------|
| "Compound not found" | Try synonyms, verify spelling, offer SMILES search |
| "No ChEMBL ID" | Note in Identity section, continue with PubChem data |
| "No bioactivity data" | Include section with "No bioactivity screening data available" |
| "API timeout" | Retry once, note unavailable data with "(retrieval failed)" |
---
## Tool Reference
**PubChem (Chemical Database)**
| Tool | Purpose |
|------|---------|
| `PubChem_get_CID_by_compound_name` | Name → CID |
| `PubChem_get_CID_by_SMILES` | Structure → CID |
| `PubChem_get_compound_properties_by_CID` | Molecular properties |
| `PubChem_get_compound_2D_image_by_CID` | Structure visualization |
| `PubChem_get_bioactivity_summary_by_CID` | Activity overview |
| `PubChem_get_drug_label_info_by_CID` | FDA drug labels |
| `PubChem_get_associated_patents_by_CID` | IP information |
| `PubChem_search_compounds_by_similarity` | Find analogs |
| `PubChem_search_compounds_by_substructure` | Substructure search |
**ChEMBL (Bioactivity Database)**
| Tool | Purpose |
|------|---------|
| `ChEMBL_search_compounds` | Name/structure search |
| `ChEMBL_get_compound_by_chemblid` | Compound details |
| `ChEMBL_get_bioactivity_by_chemblid` | Activity data |
| `ChEMBL_get_target_by_chemblid` | Protein targets |
| `ChEMBL_search_targets` | Target search |
| `ChEMBL_get_assays_by_chemblid` | Assay metadata |Related Skills
tooluniverse-target-research
Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.
tooluniverse-protein-therapeutic-design
Design novel protein therapeutics (binders, enzymes, scaffolds) using AI-guided de novo design. Uses RFdiffusion for backbone generation, ProteinMPNN for sequence design, ESMFold/AlphaFold2 for validation. Use when asked to design protein binders, therapeutic proteins, or engineer protein function.
tooluniverse-pharmacovigilance
Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.
tooluniverse-network-pharmacology
Construct and analyze compound-target-disease networks for drug repurposing, polypharmacology discovery, and systems pharmacology. Builds multi-layer networks from ChEMBL, OpenTargets, STRING, DrugBank, Reactome, FAERS, and 60+ other ToolUniverse tools. Calculates Network Pharmacology Scores (0-100), identifies repurposing candidates, predicts mechanisms, and analyzes polypharmacology. Use when users ask about drug repurposing via network analysis, multi-target drug effects, compound-target-disease networks, systems pharmacology, or polypharmacology.
tooluniverse-drug-target-validation
Comprehensive computational validation of drug targets for early-stage drug discovery. Evaluates targets across 10 dimensions (disambiguation, disease association, druggability, chemical matter, clinical precedent, safety, pathway context, validation evidence, structural insights, validation roadmap) using 60+ ToolUniverse tools. Produces a quantitative Target Validation Score (0-100) with GO/NO-GO recommendation. Use when users ask about target validation, druggability assessment, target prioritization, or "is X a good drug target for Y?"
tooluniverse-drug-research
Generates comprehensive drug research reports with compound disambiguation, evidence grading, and mandatory completeness sections. Covers identity, chemistry, pharmacology, targets, clinical trials, safety, pharmacogenomics, and ADMET properties. Use when users ask about drugs, medications, therapeutics, or need drug profiling, safety assessment, or clinical development research.
tooluniverse-drug-repurposing
Identify drug repurposing candidates using ToolUniverse for target-based, compound-based, and disease-driven strategies. Searches existing drugs for new therapeutic indications by analyzing targets, bioactivity, safety profiles, and literature evidence. Use when exploring drug repurposing opportunities, finding new indications for approved drugs, or when users mention drug repositioning, off-label uses, or therapeutic alternatives.
tooluniverse-drug-drug-interaction
Comprehensive drug-drug interaction (DDI) prediction and risk assessment. Analyzes interaction mechanisms (CYP450, transporters, pharmacodynamic), severity classification, clinical evidence grading, and provides management strategies. Supports single drug pairs, polypharmacy analysis (3+ drugs), and alternative drug recommendations. Use when users ask about drug interactions, medication safety, polypharmacy risks, or need DDI assessment for clinical decision support.
tooluniverse-chemical-safety
Comprehensive chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, FDA label safety data, DrugBank safety profiles, and STITCH chemical-protein interactions. Performs predictive toxicology (AMES, DILI, LD50, carcinogenicity), organ/system toxicity profiling, chemical-gene-disease relationship mapping, regulatory safety extraction, and environmental hazard assessment. Use when asked about chemical toxicity, drug safety profiling, ADMET properties, environmental health risks, chemical hazard assessment, or toxicogenomic analysis.
tooluniverse-binder-discovery
Discover novel small molecule binders for protein targets using structure-based and ligand-based approaches. Creates actionable reports with candidate compounds, ADMET profiles, and synthesis feasibility. Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.
tooluniverse-antibody-engineering
Comprehensive antibody engineering and optimization for therapeutic development. Covers humanization, affinity maturation, developability assessment, and immunogenicity prediction. Use when asked to optimize antibodies, humanize sequences, or engineer therapeutic antibodies from lead to clinical candidate.
tooluniverse-adverse-event-detection
Detect and analyze adverse drug event signals using FDA FAERS data, drug labels, disproportionality analysis (PRR, ROR, IC), and biomedical evidence. Generates quantitative safety signal scores (0-100) with evidence grading. Use for post-market surveillance, pharmacovigilance, drug safety assessment, adverse event investigation, and regulatory decision support.